Sotera Health Co (SHC)

Sotera Health Co experienced significant divestment activity recently, with major institutional shareholders executing substantial sales. These transactions occurred alongside a 22.2% stock price increase over the last quarter. While executives maintained their positions, the heavy volume of selling by private equity entities highlights a notable shift in ownership structure following the latest earnings report.
Ticker: SHC Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Sotera Health Co. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 7 Aug 2026
Value US$687,421.63 | Price 169.76 | Shares 52,144 (+36.3%)
Proposed sale 7 Aug 2026
Value US$1,649,186.67 | Price 90.73 | Shares 27,646
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-11 2026-08-07 S Sale

President of Sterigenics

Officer
52,144 +36.3%
169.76
US$687,422
52,144 +36.3% 169.76 US$687,422
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
27,646
90.73
US$1,649,187
27,646 90.73 US$1,649,187
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
7,854 +3.6%
401.94
US$3,151,149
7,854 +3.6% 401.94 US$3,151,149
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
19,102,952 -100.0%
15.17
US$289,753,576
19,102,952 -100.0% 15.17 US$289,753,576
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
12,735,301 -100.0%
15.17
US$193,169,046
12,735,301 -100.0% 15.17 US$193,169,046
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
12,735,301 -100.0%
15.17
US$193,169,046
12,735,301 -100.0% 15.17 US$193,169,046
2026-05-15 2026-05-13 S Sale Non-Executive Director Large shareholder
19,102,952 -100.0%
15.17
US$289,753,576
19,102,952 -100.0% 15.17 US$289,753,576
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
10,000,000 -44.0%
15.27
US$152,700,000
10,000,000 -44.0% 15.27 US$152,700,000
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
15,000,000 -44.0%
15.27
US$229,050,000
15,000,000 -44.0% 15.27 US$229,050,000
2026-03-10 2026-03-06 S Sale Non-Executive Director Large shareholder
15,000,000 -44.0%
15.27
US$229,050,000
15,000,000 -44.0% 15.27 US$229,050,000
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
39,243 -100.0%
16.45
US$645,547
39,243 -100.0% 16.45 US$645,547
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
394,861 -7.6%
16.45
US$6,495,463
394,861 -7.6% 16.45 US$6,495,463
2025-12-10 2025-12-08 S Sale

Chairman & CEO

Executive Director
315,896 -36.4%
16.45
US$5,196,489
315,896 -36.4% 16.45 US$5,196,489
2025-12-08 2025-12-08 PrS Proposed sale

Chairman, CEO

750,000
16.75
US$12,562,500
750,000 16.75 US$12,562,500
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
9,720,000 -22.2%
16.33
US$158,727,600
9,720,000 -22.2% 16.33 US$158,727,600
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
9,720,000 -22.2%
16.33
US$158,727,600
9,720,000 -22.2% 16.33 US$158,727,600
2025-12-05 2025-12-03 S Sale Non-Executive Director Large shareholder
6,480,000 -22.2%
16.33
US$105,818,400
6,480,000 -22.2% 16.33 US$105,818,400
2025-12-04 2025-12-03 PrS Proposed sale

Owner

1,295,747
16.33
US$21,159,549
1,295,747 16.33 US$21,159,549
2025-12-03 2025-12-03 PrS Proposed sale

Owner

41,219
16.33
US$673,106
41,219 16.33 US$673,106
2025-12-03 2025-12-03 PrS Proposed sale

Owner

5,143,033
16.33
US$83,985,729
5,143,033 16.33 US$83,985,729
2025-12-03 2025-12-03 PrS Proposed sale

Affiliate

9,720,000
16.84
US$163,684,800
9,720,000 16.84 US$163,684,800
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
12,000,000 -29.1%
15.65
US$187,812,000
12,000,000 -29.1% 15.65 US$187,812,000
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
18,000,000 -29.1%
15.65
US$281,718,000
18,000,000 -29.1% 15.65 US$281,718,000
2025-11-12 2025-11-10 S Sale Non-Executive Director Large shareholder
18,000,000 -29.1%
15.65
US$281,718,000
18,000,000 -29.1% 15.65 US$281,718,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
12,000,000 -16.3%
15.11
US$181,332,000
12,000,000 -16.3% 15.11 US$181,332,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
12,000,000 -16.3%
15.11
US$181,332,000
12,000,000 -16.3% 15.11 US$181,332,000
2025-09-09 2025-09-05 S Sale Non-Executive Director Large shareholder
8,000,000 -16.3%
15.11
US$120,888,000
8,000,000 -16.3% 15.11 US$120,888,000
2025-08-26 2025-08-22 S Sale

President of Sterigenics

Officer
126,611 -22.0%
16.38
US$2,074,306
126,611 -22.0% 16.38 US$2,074,306
2025-08-22 2025-08-22 PrS Proposed sale

Officer

Officer
126,611
16.12
US$2,040,969
126,611 16.12 US$2,040,969
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
10,000,000 -16.9%
15.03
US$150,300,000
10,000,000 -16.9% 15.03 US$150,300,000
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
15,000,000 -16.9%
15.03
US$225,450,000
15,000,000 -16.9% 15.03 US$225,450,000
2024-09-09 2024-09-06 S Sale Non-Executive Director Large shareholder
15,000,000 -16.9%
15.03
US$225,450,000
15,000,000 -16.9% 15.03 US$225,450,000
2024-03-06 2024-03-04 S Sale Non-Executive Director
5,750 -6.2%
14.31
US$82,268
5,750 -6.2% 14.31 US$82,268
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
16,594,363 -15.7%
14.31
US$237,423,849
16,594,363 -15.7% 14.31 US$237,423,849
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
16,594,363 -15.7%
14.31
US$237,423,849
16,594,363 -15.7% 14.31 US$237,423,849
2024-03-06 2024-03-04 S Sale Non-Executive Director Large shareholder
11,062,908 -15.7%
14.31
US$158,282,556
11,062,908 -15.7% 14.31 US$158,282,556
2024-03-05 2024-03-04 S Sale

Chairman & CEO

Officer
1,003,870 -15.5%
14.31
US$14,362,870
1,003,870 -15.5% 14.31 US$14,362,870
2024-03-05 2024-03-04 S Sale

President of Sterigenics

Officer
83,109 -13.2%
14.31
US$1,189,082
83,109 -13.2% 14.31 US$1,189,082
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
13,512,582 -11.4%
26.12
US$352,982,423
13,512,582 -11.4% 26.12 US$352,982,423
2021-03-24 2021-03-22 S Sale

Chairman & CEO

Executive Director
817,439 -11.4%
26.12
US$21,353,550
817,439 -11.4% 26.12 US$21,353,550
2021-03-24 2021-03-22 S Sale

SVP, GC and Secretary

Officer
41,952 -11.4%
26.12
US$1,095,891
41,952 -11.4% 26.12 US$1,095,891
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
13,512,582 -11.4%
26.12
US$352,982,423
13,512,582 -11.4% 26.12 US$352,982,423
2021-03-24 2021-03-22 S Sale Non-Executive Director Large shareholder
9,008,388 -11.4%
26.12
US$235,321,616
9,008,388 -11.4% 26.12 US$235,321,616